Log inSign up
Genentech
7,812 posts
Genentech profile banner
@genentech

Genentech

@genentech
Official Twitter for Genentech. See our community guidelines here: ow.ly/1sSw30lmszz
USA
gene.com
Joined September 2008
225
Following
123.1K
Followers
RepliesRepliesRepostsRepostsMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • @genentech
    Genentech
    @genentech
    Aug 20
    Today we announced an expansion of our Hillsboro, OR site with a new device fill-finish facility. This investment reflects our continued commitment to Hillsboro and the region's workforce as we build end-to-end U.S. drug manufacturing capabilities:
    gene.com
    Genentech: Press Releases | Genentech Announces Manufacturing Expansion in Hillsboro, Oregon
    Discover the latest news about our company, our products, our policies, and our people.
    2
  • @genentech
    Genentech
    @genentech
    Aug 18
    Today marks a major milestone: the topping out of our first-ever East Coast manufacturing facility in Holly Springs, NC. The final beam placement reflects our progress and deep commitment to the region’s workforce, community, and long-term potential:
    gene.com
    Genentech: Press Releases | Genentech Marks Topping Out Milestone for New Holly Springs, North...
    Discover the latest news about our company, our products, our policies, and our people.
  • @genentech
    Genentech
    @genentech
    Jul 15
    #Breaking: The @US_FDA granted priority review to our treatment for primary membranous nephropathy (pMN), a chronic, idiopathic kidney condition. If approved, it would be the first FDA-approved therapy specifically indicated to treat this disease. Read more:
    00:00
  • @genentech
    Genentech
    @genentech
    Jul 7
    #Breaking: We are presenting data across our Alzheimer’s disease portfolio at #AAIC2026, highlighting our dedication to detect, slow and hopefully one day prevent this devastating disease. Learn more: gene.com/media/press-re…
    00:00
    1
  • @genentech
    Genentech
    @genentech
    Jul 2
    #Breaking: New positive Phase III results demonstrate superiority of an investigational molecule over standard-of-care KRAS G12C inhibitors in the first global head-to-head study in KRAS G12C-mutant non-small cell lung cancer: gene.com/media/press-re…
    00:00
    1